Evommune, Inc. (EVMN) is a publicly traded the market company. As of September 13, 2026, EVMN trades at $10.54 with a market cap of $382.52M and a P/E ratio of -0.94. EVMN moved -0.19% today. Year to date, EVMN is -38.43%; over the trailing twelve months it is flat. Its 52-week range spans $10.30 to $33.20. Analyst consensus is strong buy with an average price target of $27.17. Rallies surfaces EVMN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Evommune, Inc. (EVMN) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. EVMN moved -0.19% today. Analyst consensus is strong buy.
| Metric | Value |
|---|---|
| Price | $10.54 |
| Market Cap | $382.52M |
| P/E Ratio | -0.94 |
| EPS | $-11.22 |
| Dividend Yield | 0.00% |
| 52-Week High | $33.20 |
| 52-Week Low | $10.30 |
| Volume | 348.62K |
| Avg Volume | 0 |
| Revenue (TTM) | $13.00M |
| Net Income | $-68.87M |
| Gross Margin | 0.00% |
8 analysts cover EVMN: 0 strong buy, 6 buy, 2 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $27.17.